Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

Michelle Hoffman

Editor-in-Chief, Pharmaceutical Technology

See Michelle Hoffman's bio page.

Articles
Passion, Innovation, and Loss
November 2, 2011

At a time when the industry is struggling with innovation, it might do well to learn a lesson from a few great innovators.

Retrospection and Introspection at FDA
September 2, 2011

A report commissioned by FDA evaluates the QbD program.

Biosimilars or Bust
August 2, 2011

Are biosimilars the next big thing or just the next big bubble?

Legislation v. Litigation
July 2, 2011

Which route will we take to arrive at a national stem-cell policy?

Perception and Reality
May 2, 2011

Those who doubt there's faith in science, should check out our annual Bioprocessing Survey.

Bioprocessing Trends: Annual Survey
May 1, 2011

Results from our annual survey. This article contains online bonus material and is part of a special issue on Bioprocessing and Sterile Manufacturing.

Celebrity Couples to Disunite
April 2, 2011

Research and development may be headed for divorce.

Follow-Ons: The New Black?
February 2, 2011

Follow-ons were all the rage at this year's JP Morgan Healthcare Conference.

What a Piece of Work is Pharma
January 2, 2011

Capable of great works, pharma as a whole still yields to the lesser angels of its nature.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here